tm logo
K KNACK PHARMACEUTICALS YOUR HEALTH PARTNER
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 03 Nov 2022

Last Applicant/ Owned by

885 Third Avenue, 17th Floor

New York City

NY

10022

Serial Number

87818001 filed on 02th Mar 2018

Registration Number

N/A

Correspondent Address

Tomas Maria Casalins

Tomas Maria Casalins

885 Third Avenue

New York NY 10022

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

K KNACK PHARMACEUTICALS YOUR HEALTH PARTNER

Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of epilepsy disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and tr Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of epilepsy disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of Alzheimer; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for the treatment of bone disorders and bone diseases; Pharmaceutical preparations for the treatment of toxic effects; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for the prevention and treatment of hormone disorders and deficiencies; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of nausea and vomiting; Pharmaceutical preparations for the prevention and treatment of aids-related disorders and diseases; Pharmaceutical preparations for treatment and prevention of viral and bacterial infections; Pharmaceutical preparations, namely, injectable contraceptives


First Use Date in General

01st Aug 2021

First Use Date in Commerce

01st Aug 2021

Mark Details


Serial Number

No 87818001

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

09.01.04 -

Ribbons, bows

24.07.08 -

Ribbons to raise awareness or support for causes

26.09.02 -

Plain single line squares

27.01.04 -

Letters or numerals, including punctuation, forming representations of objects, parts of objects, or maps

27.03.01 -

Geometric figures forming letters or numerals, including punctuation

Legal History


Show more

Status DateAction Taken
04th Nov 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
03rd Nov 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
03rd Nov 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
21st Apr 2022SU - FINAL REFUSAL - WRITTEN
21st Apr 2022FINAL REFUSAL E-MAILED
21st Apr 2022NOTIFICATION OF FINAL REFUSAL EMAILED
28th Mar 2022ASSIGNED TO EXAMINER
23rd Mar 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
23rd Mar 2022TEAS/EMAIL CORRESPONDENCE ENTERED
16th Mar 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED